We propose an in vitro model of chronic oxidative stress based on the use of glucose oxidase. Oxidative stress modeling leads to a significant increase in the number of dead cells in culture. It was shown that the glial cell-derived neurotrophic factor exhibits a pronounced anti-oxidant effect. Preventive application of 1 ng/ml glial cell-derived neurotrophic factor significantly reduced the percentage of dead cells in culture.
Similar content being viewed by others
References
Shirokova OM, Frumkina LE, Vedunova MV, Mitroshina EV, Zakharov YuN, Khaspekov LG, Mukhina IV. Morphofunctional patterns of neuronal network development in dissociated hippocampal cell cultures. Sovremen. Tekhnol. Med. 2013;5(2):6-13. Russian.
Duarte EP, Curcio M, Canzoniero LM, Duarte CB. Neuroprotection by GDNF in the ischemic brain. Growth Factors. 2012;30(4):242-257.
Fan CH, Ting CY, Lin CY, Chan HL, Chang YC, Chen YY, Liu HL, Yeh CK. Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease. Sci. Rep. 2016;6:19579. doi: https://doi.org/10.1038/srep19579.
Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 1996;85(7):1113-1124.
Konishi Y, Yang LB, He P, Lindholm K, Lu B, Li R, Shen Y. Deficiency of GDNF Receptor GFRα1 in Alzheimer’s Neurons Results in Neuronal Death. J. Neurosci. 2014;34(39):13 127-13 138.
Liu Y, Wang S, Luo S, Li Z, Liang F, Zhu Y, Pei Z, Huang R. Intravenous PEP-1-GDNF is protective after focal cerebral ischemia in rats. Neurosci. Lett. 2016;617:150-155.
Marsh SE, Blurton-Jones M. Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support. Neurochem. Int. 2017;106:94-100.
Shishkina TV, Mishchenko TA, Mitroshina EV, Shirokova OM, Pimashkin AS, Kastalskiy IA, Mukhina IV, Kazantsev VB, Vedunova MV. Glial cell line-derived neurotrophic factor (GDNF) counteracts hypoxic damage to hippocampal neural network function in vitro. Brain Res. 2018;1678:310-321.
Sopova K, Gatsiou K, Stellos K, Laske C. Dysregulation of neurotrophic and haematopoietic growth factors in Alzheimer’s disease: from pathophysiology to novel treatment strategies. Curr. Alzheimer Res. 2014;11(1):27-39.
Tome D, Fonseca CP, Campos FL, Baltazar G. Role of Neurotrophic Factors in Parkinson’s Disease. Curr. Pharm. Des. 2017;23(5):809-838.
Vedunova M, Sakharnova T, Mitroshina E, Perminova M, Pimashkin A, Zakharov Y, Dityatev A, Mukhina I. Seizure-like activity in hyaluronidase-treated dissociated hippocampal cultures. Front. Cell. Neurosci. 2013;7:149. doi: https://doi.org/10.3389/fncel.2013.00149.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 166, No. 8, pp. 257-260, August, 2018
Rights and permissions
About this article
Cite this article
Mishchenko, T.A., Mitroshina, E.V., Shishkina, T.V. et al. Antioxidant Properties of Glial Cell-Derived Neurotrophic Factor (GDNF). Bull Exp Biol Med 166, 293–296 (2018). https://doi.org/10.1007/s10517-018-4335-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4335-z